*Corresponding author:
Tomasz Mazurek, Chair and Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, 02-097 Warsaw, PolandReceived: April 25, 2018; Published: May 09,2018
DOI: 10.26717/BJSTR.2018.04.001055
To view the Full Article Peer-reviewed Article PDF
Atrial fibrillation (AF) is the most common arrhythmia and affects 1% of the population. It is associated with the need for oral anticoagulation therapy for stroke prevention. Based on the fact that more than 90% of stroke causing thrombus has its origin within the left atrial appendage (LAA) [1], nonpharmacological approaches such as isolation of LAA from the blood circulation were proposed. However, this invasive way of stroke prevention has its own risk related to the device and procedure.
Keywords: Atrial fibrillation; Left Atrial Appendage Closure; Pericardial effusion
Abbreviation: AF: Atrial Fibrillation; NVAF: Non-Valvular Atrial Fibrillation; LAA: Left Atrial Appendage; LAAC: Left Atrial Appendage Closure; NYHA: New York Heat Association; TTE: Transthoracic Echocardiography; TEE: Transesophageal Echocardiography; INR: International Normalized Ratio; TEE: Transesophageal Echocardiography; IAS: Interatrial Septum; UFH: Un Fractionated Heparin; RV: Right Ventricle; ACT: Activated Clotting Time3. Abbreviations: AF: Atrial Fibrillation; NVAF: Non-Valvular Atrial Fibrillation; LAA: Left Atrial Appendage; LAAC: Left Atrial Appendage Closure; NYHA: New York Heat Association; TTE: Transthoracic Echocardiography; TEE: Transesophageal Echocardiography; INR: International Normalized Ratio; TEE: Transesophageal Echocardiography; IAS: Interatrial Septum; UFH: Un Fractionated Heparin; RV: Right Ventricle; ACT: Activated Clotting Time
Abstract| Introduction| Case Report| Discussion| Conclusion| References|